NIH-funded research R01 grant

BOLSTER: Strengthening Care for Advanced Cancer Patients and Their Caregivers

Official title: BOLSTER: Strengthening Patient and Caregiver Supports in Advanced Cancer - a Multi-Site Randomized Controlled Trial

Funded at Dana-Farber Cancer Inst · NIH-11389158 · Data updated 2026-11-12

A multi-site trial tests a bundled, patient- and caregiver-centered palliative care program to improve quality of life and reduce hospital visits for people with advanced solid tumors.

More Randomized Controlled Trial research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDana-Farber Cancer Inst
NIH-funded
Lab location1 site (Boston, United States)
Project startFebruary 1, 2023
Project endJuly 31, 2028
Funding year2026
Award (this year)$669,032
NIH project number5R01CA270040-04
Project IDNIH-11389158 on NIH RePORTER

Who could benefit from this research

Could help

Adults with advanced solid tumors (GI/GYN/breast/lung cancers) experiencing complex care needs and caregiver involvement.

Less likely to help

Patients with contraindications to palliative care or those not experiencing high symptom burden may see limited benefit.

What this research studies

This project tests BOLSTER, a multi-component palliative care program for patients with advanced cancers such as breast, GI, gynecologic, and lung cancers. The program pairs a nurse with the patient and family caregiver for ongoing telehealth support, uses a mobile health platform to track symptoms, and provides tailored symptom management and caregiver training. The goal is to ease difficult symptoms, prevent unnecessary hospitalizations, and help families manage complex care at home. The study builds on prior pilot work and will implement the program across multiple sites with careful monitoring of outcomes.

Why it matters

Potential benefit: If successful, patients may experience better symptom control, higher quality of life, and fewer hospital visits, easing the burden on caregivers.

How similar studies have gone: Preliminary pilot data showed the program is feasible and acceptable, supporting a next-step randomized trial.

Where this research is happening

  • Dana-Farber Cancer Inst
    Boston, United States
    Active

Researchers

  • Principal investigator: Wright, Alexi a — Dana-Farber Cancer Inst
  • Study coordinator: Wright, Alexi a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.